Category : Pediatric Orthopedics / Orthopaedics
A phase three global clinical trial has shown that the drug vosoritide restores close-to-average bone growth rates of children with achondroplasia, the most common form of dwarfism.
Source : ScienceDaily
On : 01-Oct-2020